Anja Health Appoints Stem Cell Banking Veteran Jan Chen as CEO

Anja Health, a provider of cord blood, cord tissue, and placental tissue banking services, has announced the appointment of Jan Chen as its new Chief Executive Officer. Based in Los Angeles, the company aims to enhance its family-focused approach to preserving biological resources available at birth.

A Veteran Leader in Regenerative Medicine

Jan Chen joins the organization with 18 years of experience in family healthcare services and stem cell banking. Throughout her career, she has worked with tens of thousands of families across North America to help them understand the potential of regenerative medicine.

Before stepping into the CEO role, Chen served as the Head of International Sales at FamilyCord. In that position, she was instrumental in expanding access to stem cell preservation programs for diverse communities in Canada and the United States.

Chen’s professional background includes extensive collaboration with a wide range of medical experts. This includes working closely with midwives, hospitals, fertility specialists, obstetricians, surrogacy professionals, and other healthcare providers.

Did You Know? Jan Chen’s industry experience includes a previous leadership role as the Head of International Sales at FamilyCord, where she focused on expanding preservation programs across North America.

Strategic Vision and Partnerships

The appointment is part of a broader effort by Anja Health to invest in experienced leadership and family education. The company seeks to provide transparent and accessible services for parents looking to protect newborn stem cells.

Stem Cell Banking: A Health Game-Changer | Austin Yoshino from Anja Health

“As both a mother and a stem cell banking professional, I understand the importance of giving families access to trusted information, quality services, and compassionate support during one of life’s most important moments,” Chen stated.

To maintain high standards of laboratory expertise, Anja Health partners with the Vitalant Cord Blood Stem Cell Laboratory. This partnership combines cellular therapy experience with personalized support for families.

Expert Insight: Samantha Carter notes that bringing in a leader with nearly two decades of specialized experience suggests a strategic move to scale operations. By leveraging existing relationships with diverse healthcare providers, the company is likely positioned to increase the accessibility of regenerative medicine resources.

Future Outlook for Anja Health

Under Chen’s leadership, Anja Health may focus on expanding its reach to more families seeking stem cell banking options. A key priority is likely to be the strengthening of partnerships with healthcare providers to streamline the preservation process.

View this post on Instagram about Anja Health, Jan Chen

From Instagram — related to Anja Health, Jan Chen

The company could also seek to enhance the overall family experience by integrating more educational resources. This approach may help parents better navigate the complexities of preserving biological resources for future medical advances.

Kathryn Cross, the founder of Anja Health, expressed confidence in the transition, noting that Chen’s passion for supporting families makes her an exceptional addition to the team.

Frequently Asked Questions

What services does Anja Health provide?
Anja Health provides banking services for cord blood, cord tissue, and placental tissue to help families preserve biological resources available only at birth.

Who is the new CEO of Anja Health?
Jan Chen, an industry veteran with 18 years of experience in stem cell banking and family healthcare, has been appointed as CEO.

Which laboratory does Anja Health partner with?
Anja Health partners with the Vitalant Cord Blood Stem Cell Laboratory to provide cellular therapy services and laboratory expertise.

For more information, visit anjahealth.com.

How do you feel about the role of regenerative medicine in future healthcare for children?